These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25409711)

  • 1. High mobility group A1 protein expression reduces the sensitivity of colon and thyroid cancer cells to antineoplastic drugs.
    D'Angelo D; Mussnich P; Rosa R; Bianco R; Tortora G; Fusco A
    BMC Cancer; 2014 Nov; 14():851. PubMed ID: 25409711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-mediated RNA interference of HMGA1 promotes chemosensitivity to gemcitabine in pancreatic adenocarcinoma.
    Liau SS; Ashley SW; Whang EE
    J Gastrointest Surg; 2006 Nov; 10(9):1254-62; discussion 1263. PubMed ID: 17114012
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Silencing of high mobility group A1 enhances gemcitabine chemosensitivity of lung adenocarcinoma cells.
    Cao YD; Huang PL; Sun XC; Ma J; Jin ZL; Cheng HY; Xu RZ; Li F; Qin SK; Deng YX; Ge XL
    Chin Med J (Engl); 2011 Apr; 124(7):1061-8. PubMed ID: 21542969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of HMGA1 promotes anoikis resistance and constitutive Akt activation in pancreatic adenocarcinoma cells.
    Liau SS; Jazag A; Ito K; Whang EE
    Br J Cancer; 2007 Mar; 96(6):993-1000. PubMed ID: 17342093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased TGF-α as a mechanism of acquired resistance to the anti-EGFR inhibitor cetuximab through EGFR-MET interaction and activation of MET signaling in colon cancer cells.
    Troiani T; Martinelli E; Napolitano S; Vitagliano D; Ciuffreda LP; Costantino S; Morgillo F; Capasso A; Sforza V; Nappi A; De Palma R; D'Aiuto E; Berrino L; Bianco R; Ciardiello F
    Clin Cancer Res; 2013 Dec; 19(24):6751-65. PubMed ID: 24122793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Critical role of HMGA proteins in cancer cell chemoresistance.
    D'Angelo D; Mussnich P; Arra C; Battista S; Fusco A
    J Mol Med (Berl); 2017 Apr; 95(4):353-360. PubMed ID: 28293697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMGA proteins promote ATM expression and enhance cancer cell resistance to genotoxic agents.
    Palmieri D; Valentino T; D'Angelo D; De Martino I; Postiglione I; Pacelli R; Croce CM; Fedele M; Fusco A
    Oncogene; 2011 Jul; 30(27):3024-35. PubMed ID: 21339738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR9 agonist acts by different mechanisms synergizing with bevacizumab in sensitive and cetuximab-resistant colon cancer xenografts.
    Damiano V; Caputo R; Garofalo S; Bianco R; Rosa R; Merola G; Gelardi T; Racioppi L; Fontanini G; De Placido S; Kandimalla ER; Agrawal S; Ciardiello F; Tortora G
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12468-73. PubMed ID: 17636117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HMGA1 protein expression sensitizes cells to cisplatin-induced cell death.
    Baldassarre G; Belletti B; Battista S; Nicoloso MS; Pentimalli F; Fedele M; Croce CM; Fusco A
    Oncogene; 2005 Oct; 24(45):6809-19. PubMed ID: 16007157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel toll-like receptor 9 agonist induces epidermal growth factor receptor (EGFR) inhibition and synergistic antitumor activity with EGFR inhibitors.
    Damiano V; Caputo R; Bianco R; D'Armiento FP; Leonardi A; De Placido S; Bianco AR; Agrawal S; Ciardiello F; Tortora G
    Clin Cancer Res; 2006 Jan; 12(2):577-83. PubMed ID: 16428503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA let‑7d‑5p rescues ovarian cancer cell apoptosis and restores chemosensitivity by regulating the p53 signaling pathway via HMGA1.
    Chen YN; Ren CC; Yang L; Nai MM; Xu YM; Zhang F; Liu Y
    Int J Oncol; 2019 May; 54(5):1771-1784. PubMed ID: 30816441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TGF-β1 induces HMGA1 expression in human breast cancer cells: implications of the involvement of HMGA1 in TGF-β signaling.
    Zu X; Zhong J; Tan J; Tan L; Yang D; Zhang Q; Ding W; Liu W; Wen G; Liu J; Cao R; Jiang Y
    Int J Mol Med; 2015 Mar; 35(3):693-701. PubMed ID: 25572132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HMGA1 pseudogenes as candidate proto-oncogenic competitive endogenous RNAs.
    Esposito F; De Martino M; Petti MG; Forzati F; Tornincasa M; Federico A; Arra C; Pierantoni GM; Fusco A
    Oncotarget; 2014 Sep; 5(18):8341-54. PubMed ID: 25268743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impairment of the High Mobility Group A (HMGA) protein function contributes to the anticancer activity of trabectedin.
    D'Angelo D; Borbone E; Palmieri D; Uboldi S; Esposito F; Frapolli R; Pacelli R; D'Incalci M; Fusco A
    Eur J Cancer; 2013 Mar; 49(5):1142-51. PubMed ID: 23149213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular aspects on adriamycin interaction with hmga1 regulatory region and its inhibitory effect on HMGA1 expression in human cervical cancer.
    Akhter MZ; Luthra K; Rajeswari MR
    J Biomol Struct Dyn; 2016; 34(4):877-91. PubMed ID: 26084422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effects of small interfering RNA specific to stably transfected HMGA1 gene on biological characters of ovarian carcinoma cells].
    Liu YL; Zheng JH
    Zhonghua Fu Chan Ke Za Zhi; 2010 Jan; 45(1):51-5. PubMed ID: 20367927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA1 induces intestinal polyposis in transgenic mice and drives tumor progression and stem cell properties in colon cancer cells.
    Belton A; Gabrovsky A; Bae YK; Reeves R; Iacobuzio-Donahue C; Huso DL; Resar LM
    PLoS One; 2012; 7(1):e30034. PubMed ID: 22276142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bcl-2 overexpression in thyroid carcinoma cells increases sensitivity to Bcl-2 homology 3 domain inhibition.
    Mitsiades CS; Hayden P; Kotoula V; McMillin DW; McMullan C; Negri J; Delmore JE; Poulaki V; Mitsiades N
    J Clin Endocrinol Metab; 2007 Dec; 92(12):4845-52. PubMed ID: 17848408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidrug mediated re-expression of miRNA targeting the HMGA transcripts in pituitary cells.
    Kitchen MO; Yacqub-Usman K; Emes RD; Richardson A; Clayton RN; Farrell WE
    Pituitary; 2015 Oct; 18(5):674-84. PubMed ID: 25557289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered expression of c-IAP1, survivin, and Smac contributes to chemotherapy resistance in thyroid cancer cells.
    Tirrò E; Consoli ML; Massimino M; Manzella L; Frasca F; Sciacca L; Vicari L; Stassi G; Messina L; Messina A; Vigneri P
    Cancer Res; 2006 Apr; 66(8):4263-72. PubMed ID: 16618750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.